Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-018200
Filing Date
2019-09-16
Accepted
2019-09-16 18:08:36
Documents
1
Period of Report
2019-09-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6052
  Complete submission text file 0001213900-19-018200.txt   7571
Mailing Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 36 CHURCH LANE WESTPORT CT 06880
Business Address
RAKIN KEVIN (Reporting) CIK: 0001184421 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 191095651